CAG
THC icon

Crestwood Advisors Group’s Tenet Healthcare THC Stock Holding History

Crestwood Advisors Group’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Sell
2,702
-353
-12% -$64.9K 0.01% 483
2026
Q1 		$577K Buy
3,055
+103
+3% +$21.7K 0.01% 385
2025
Q4 		$587K Buy
2,952
+346
+13% +$69.9K 0.01% 362
2025
Q3 		$529K Buy
2,606
+64
+3% +$11.4K 0.01% 356
2025
Q2 		$447K Buy
2,542
+18
+0.7% +$2.71K 0.01% 366
2025
Q1 		$339K Sell
2,524
-134
-5% -$17.6K 0.01% 400
2024
Q4 		$336K Sell
2,658
-25
-0.9% -$3.72K 0.01% 367
2024
Q3 		$446K Buy
2,683
+21
+0.8% +$3.18K 0.01% 306
2024
Q2 		$354K Buy
2,662
+8
+0.3% +$963 0.01% 326
2024
Q1 		$279K Hold
2,654
– – 0.01% 367
2023
Q4 		$201K Buy
+2,654
New +$168K ﹤0.01% 392
2022
Q2 		– Sell
-2,442
Closed -$210K – 292
2022
Q1 		$210K Buy
+2,442
New +$201K 0.01% 269

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Crestwood Advisors Group's THC Position: Q2 2026 in Review

Crestwood Advisors Group reduced its Tenet Healthcare (THC) stake by 12% in Q2 2026, selling an estimated $64.9K and leaving 2,702 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #483.

Crestwood Advisors Group first reported a position in THC in Q1 2022 and has held it in 12 quarters since. The position peaked at $587K in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Crestwood Advisors Group held 2,702 shares of Tenet Healthcare worth $505K as of Q2 2026.
  • Crestwood Advisors Group sold 353 Tenet Healthcare shares in Q2 2026, an estimated $64.9K.
  • Tenet Healthcare made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #483 holding.
  • Crestwood Advisors Group first reported a position in Tenet Healthcare in Q1 2022 and has held it in 12 quarters since.
  • Crestwood Advisors Group's Tenet Healthcare position peaked at $587K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.